Cited by

• Phase I study of docetaxel plus S-1 combination chemotherapy for recurrent non-small cell lung cancer.

  Fujitaka K, Hattori N, Senoo T, Iwamoto H, Ohshimo S, Kanehara M, Ishikawa N, Haruta Y, Murai H, Kohno N. Fujitaka K, et al. Oncol Lett. 2011 Jan;2(1):167-170. doi: 10.3892/ol.2010.218. Epub 2010 Nov 23. Oncol Lett. 2011. PMID: 22870147 Free PMC article.
• Clinical Trials for Oral, Inhaled and Intravenous Drug Delivery System for Lung Cancer and Emerging Nanomedicine-Based Approaches.

  Aryal S, Park S, Park H, Park C, Kim WC, Thakur D, Won YJ, Key J. Aryal S, et al. Int J Nanomedicine. 2023 Dec 21;18:7865-7888. doi: 10.2147/IJN.S432839. eCollection 2023. Int J Nanomedicine. 2023. PMID: 38146467 Free PMC article. Review.
• miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells.

  Chen G, Umelo IA, Lv S, Teugels E, Fostier K, Kronenberger P, Dewaele A, Sadones J, Geers C, De Grève J. Chen G, et al. PLoS One. 2013;8(3):e60317. doi: 10.1371/journal.pone.0060317. Epub 2013 Mar 26. PLoS One. 2013. PMID: 23555954 Free PMC article.
• S-1 plus cisplatin with concurrent radiotherapy versus cisplatin alone with concurrent radiotherapy for stage III non-small cell lung cancer: a pilot randomized controlled trial.

  Yao L, Xu S, Xu J, Yang C, Wang J, Sun D. Yao L, et al. Radiat Oncol. 2015 Jan 9;10:10. doi: 10.1186/s13014-014-0306-3. Radiat Oncol. 2015. PMID: 25572571 Free PMC article. Clinical Trial.
• Impact of age and comorbidity on non-small-cell lung cancer treatment in older veterans.

  Wang S, Wong ML, Hamilton N, Davoren JB, Jahan TM, Walter LC. Wang S, et al. J Clin Oncol. 2012 May 1;30(13):1447-55. doi: 10.1200/JCO.2011.39.5269. Epub 2012 Mar 26. J Clin Oncol. 2012. PMID: 22454424 Free PMC article.